Clinical Trial Update: The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1 [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dexamethasone ophthalmic insert timing (in OR day of surgery vs in-office post-op day 1) for cataract patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Dexamethasone ophthalmic insert

Snippet

Sponsor: Grene Vision Group | Conditions: Cataract | Phase 4 | Status: COMPLETED